China-based PackGene LLC has entered into a partnership with compatriot firm Genemagic Biosciences Co., Ltd. Under the agreement, PackGene will provide Genemagic with Contract Development and Manufacturing Organization (CDMO) services for the large-scale production of adeno-associated virus (AAV). In return, Genemagic will assist PackGene in enhancing its π-beta SF9 AAV high-yield platform manufacturing capacities.
Company Profiles
Genemagic, founded in 2020, is a biotech company focused on the development of regenerative therapies for central nervous system diseases, eye diseases, ear diseases, and others. It possesses editing protein development and high-throughput AAV capsid engineering platforms. PackGene, on the other hand, is a Contract Research Organization (CRO) and Contract Testing, Development, and Manufacturing Organization (CTDMO) specializing in recombinant adeno-associated virus (rAAV) vector packaging.-Fineline Info & Tech
